Norges Bank’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
+71,000
| New | +$1.05M | ﹤0.01% | 1536 |
|
|
2025
Q1 | – | Sell |
-71,000
| Closed | -$1.24M | – | 1571 |
|
|
2024
Q4 | $1.24M | Buy |
+71,000
| New | +$1.24M | ﹤0.01% | 1741 |
|
|
2024
Q3 | – | Sell |
-71,000
| Closed | -$584K | – | 1646 |
|
|
2024
Q2 | $584K | Hold |
71,000
| – | – | ﹤0.01% | 1869 |
|
|
2024
Q1 | $547K | Hold |
71,000
| – | – | ﹤0.01% | 1836 |
|
|
2023
Q4 | $638K | Hold |
71,000
| – | – | ﹤0.01% | 1891 |
|
|
2023
Q3 | $635K | Hold |
71,000
| – | – | ﹤0.01% | 1911 |
|
|
2023
Q2 | $1.09M | Hold |
71,000
| – | – | ﹤0.01% | 1925 |
|
|
2023
Q1 | $1.6M | Sell |
71,000
-144,000
| -67% | -$3.24M | ﹤0.01% | 1949 |
|
|
2022
Q4 | $4.52M | Sell |
215,000
-20,900
| -9% | -$440K | ﹤0.01% | 1809 |
|
|
2022
Q3 | $5.81M | Buy |
235,900
+144,000
| +157% | +$3.55M | ﹤0.01% | 1708 |
|
|
2022
Q2 | $2.23M | Buy |
+91,900
| New | +$2.23M | ﹤0.01% | 1887 |
|
|
2021
Q1 | – | Sell |
-24,690
| Closed | -$673K | – | 2196 |
|
|
2020
Q4 | $673K | Hold |
24,690
| – | – | ﹤0.01% | 2063 |
|
|
2020
Q3 | $456K | Buy |
+24,690
| New | +$456K | ﹤0.01% | 2086 |
|